CONMED CORPORATION Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
CONMED CORPORATION (CNMD) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of $684.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2026-02-17
- CONMED CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2025 was $684.00K, a 95.43% increase from fiscal 2024.
- CONMED CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2024 was $350.00K.
- CONMED CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2023 was $0.00.
- CONMED CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2022 was $0.00.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month |
|---|---|
| 2025-12-31 | $684.00K 10-K · filed 2026-02-17 |
| 2024-12-31 | $350.00K 10-K · filed 2026-02-17 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-17 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-18 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2020-12-31 | $1.97M 10-K · filed 2023-02-21 |
| 2019-12-31 | $2.40M 10-K · filed 2022-02-22 |
| 2018-12-31 | $370.00K 10-K · filed 2021-02-22 |
| 2017-12-31 | $607.00K 10-K · filed 2020-02-24 |
| 2016-12-31 | $361.00K 10-K · filed 2019-02-25 |
| 2015-12-31 | $0.00 10-K · filed 2018-02-26 |
| 2014-12-31 | $1.07M 10-K · filed 2017-02-27 |
| 2013-12-31 | $1.01M 10-K · filed 2016-02-23 |
| 2012-12-31 | $1.86M 10-K · filed 2015-02-23 |
| 2011-12-31 | $0.00 10-K · filed 2014-02-24 |
| 2010-12-31 | $757.00K 10-K · filed 2013-02-25 |
| 2009-12-31 | $1.32M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |